{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:32:32Z","timestamp":1759588352107},"reference-count":70,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the occurrence of dyslipidemia and its contribution to the development of insulin resistance in obese subjects, a growing number of studies have described abnormal lipid profiles among leaner persons. For example, individuals with an abnormal paucity or distribution of fat (lipodystrophy) develop severe insulin resistance, dyslipidemia, and hepatic steatosis. Deranged adipocyte metabolism and differentiation contribute to ectopic fat deposition and consequent development of insulin resistance. Growth hormone (GH) therapy has been shown to correct body composition abnormalities in some lipodystrophy patients. However, little is known about the effects of GH-releasing peptides in this regard. Hexarelin, a GH secretagogue, has recently been shown to have beneficial effects on fat metabolism via the CD36 receptor. In this study, the effects of twice daily intraperitoneal injections of hexarelin (200 \u03bcg\/kg body weight) were examined in nonobese insulin-resistant MKR mice and corresponding wild-type FVB mice for 12 days. Hexarelin treatment significantly improved glucose and insulin intolerance and decreased plasma and liver triglycerides in MKR mice. These beneficial metabolic effects could be due to the improved lipid metabolism and enhanced adipocyte differentiation of white adipose tissue with hexarelin treatment. Interestingly, although food intake of hexarelin-treated MKR mice was significantly increased, this did not change total body weight. Moreover, hexarelin treatment corrected the abnormal body composition of MKR mice, as demonstrated by a decrease in fat mass and an increase in lean mass. Our results suggest a possible application of hexarelin in treatment of lipid disorders associated with the metabolic syndrome.<\/jats:p>","DOI":"10.1210\/en.2017-00168","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T18:03:54Z","timestamp":1500055434000},"page":"3174-3187","source":"Crossref","is-referenced-by-count":10,"title":["Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice"],"prefix":"10.1210","volume":"158","author":[{"given":"Rasha","family":"Mosa","sequence":"first","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Medicine, University of Queensland, St. Lucia, Queensland 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Medicine, University of Queensland, St. Lucia, Queensland 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeda","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Medicine, University of Queensland, St. Lucia, Queensland 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chungyan","family":"Fung","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Medicine, University of Queensland, St. Lucia, Queensland 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oshini","family":"Mallawakankanamalage","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Medicine, University of Queensland, St. Lucia, Queensland 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"LeRoith","sequence":"additional","affiliation":[{"name":"Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Medicine, University of Queensland, St. Lucia, Queensland 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"key":"2020071621531374000_B1","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1046\/j.1462-8902.2003.0310.x","article-title":"Lipoprotein abnormalities and their consequences for patients with type 2 diabetes","volume":"5","author":"Krentz","year":"2003","journal-title":"Diabetes Obes Metab"},{"issue":"52","key":"2020071621531374000_B2","doi-asserted-by":"crossref","first-page":"50230","DOI":"10.1074\/jbc.M200958200","article-title":"Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle","volume":"277","author":"Yu","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"2020071621531374000_B3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/diabetes.53.1.25","article-title":"Ceramide content is increased in skeletal muscle from obese insulin-resistant humans","volume":"53","author":"Adams","year":"2004","journal-title":"Diabetes"},{"key":"2020071621531374000_B4","first-page":"3","article-title":"The lean patient with type 2 diabetes: characteristics and therapy challenge","volume":"153","author":"Brunetti","year":"2007","journal-title":"Int J Clin Pract Suppl"},{"issue":"1","key":"2020071621531374000_B5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jacc.2016.03.597","article-title":"Ectopic and visceral fat deposition in\u00a0lean and obese patients with type\u00a02\u00a0diabetes","volume":"68","author":"Levelt","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2020071621531374000_B6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/jc.2003-030723","article-title":"Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach","volume":"89","author":"Bays","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2020071621531374000_B7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0026-0495(79)90090-8","article-title":"The effect of diet on thermogenesis in acquired lipodystrophy","volume":"28","author":"Robbins","year":"1979","journal-title":"Metabolism"},{"key":"2020071621531374000_B8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1749-6632.1999.tb07802.x","article-title":"Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes","volume":"892","author":"Reitman","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2020071621531374000_B9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/emmm.200900037","article-title":"Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC","volume":"1","author":"Rubio-Cabezas","year":"2009","journal-title":"EMBO Mol Med"},{"key":"2020071621531374000_B10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.biochi.2015.10.024","article-title":"Adipocyte lipolysis and insulin resistance","volume":"125","author":"Morigny","year":"2016","journal-title":"Biochimie"},{"issue":"2","key":"2020071621531374000_B11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/diab.20.2.65","article-title":"Insulin secretion in relation to adipose tissue in men","volume":"20","author":"Bj\u00f6rntorp","year":"1971","journal-title":"Diabetes"},{"issue":"12","key":"2020071621531374000_B12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s001250051560","article-title":"Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance","volume":"43","author":"Weyer","year":"2000","journal-title":"Diabetologia"},{"issue":"1","key":"2020071621531374000_B13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2337\/diabetes.50.1.123","article-title":"Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats","volume":"50","author":"Dobbins","year":"2001","journal-title":"Diabetes"},{"issue":"9","key":"2020071621531374000_B14","first-page":"667","article-title":"Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore Longitudinal Study on Aging","volume":"16","author":"Seidell","year":"1992","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"3","key":"2020071621531374000_B15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/JOE-10-0272","article-title":"Lipodystrophy: metabolic insights from a rare disorder","volume":"207","author":"Huang-Doran","year":"2010","journal-title":"J Endocrinol"},{"issue":"3","key":"2020071621531374000_B16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1191\/1358863x04vm568xx","article-title":"Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. N Engl J Med 2004; 350: 664\u201371","volume":"9","author":"Razak","year":"2004","journal-title":"Vasc Med"},{"issue":"6","key":"2020071621531374000_B17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.diabet.2015.09.003","article-title":"Effects of a very low-calorie diet on insulin sensitivity and insulin secretion in overweight\/obese and lean type 2 diabetes patients","volume":"41","author":"Liu","year":"2015","journal-title":"Diabetes Metab"},{"issue":"7","key":"2020071621531374000_B18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1468-1293.2007.00488.x","article-title":"A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy","volume":"8","author":"Kohli","year":"2007","journal-title":"HIV Med"},{"issue":"15","key":"2020071621531374000_B19","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00002030-199910220-00013","article-title":"Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV","volume":"13","author":"Wanke","year":"1999","journal-title":"AIDS"},{"issue":"8","key":"2020071621531374000_B20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1468-1293.2010.00906.x","article-title":"Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials","volume":"12","author":"Sivakumar","year":"2011","journal-title":"HIV Med"},{"issue":"1","key":"2020071621531374000_B21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03345474","article-title":"Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing\u2019s disease","volume":"22","author":"Arvat","year":"1999","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2020071621531374000_B22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jssc.201501060","article-title":"Simplifying and expanding the screening for peptides &lt;2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry","volume":"39","author":"Thomas","year":"2016","journal-title":"J Sep Sci"},{"issue":"3","key":"2020071621531374000_B23","first-page":"253","article-title":"The cardiovascular action of hexarelin","volume":"11","author":"Mao","year":"2014","journal-title":"J Geriatr Cardiol"},{"issue":"2","key":"2020071621531374000_B24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1388-9842(01)00223-9","article-title":"GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy","volume":"4","author":"Imazio","year":"2002","journal-title":"Eur J Heart Fail"},{"issue":"2-3","key":"2020071621531374000_B25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(02)01934-9","article-title":"Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery","volume":"448","author":"Broglio","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"2020071621531374000_B26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1096-6374(98)80041-5","article-title":"Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats","volume":"8","author":"Berti","year":"1998","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"2020071621531374000_B27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/en.2006-0975","article-title":"A growth hormone-releasing peptide promotes mitochondrial biogenesis and a fat burning-like phenotype through scavenger receptor CD36 in white adipocytes","volume":"148","author":"Rodrigue-Way","year":"2007","journal-title":"Endocrinology"},{"issue":"21","key":"2020071621531374000_B28","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1128\/MCB.00138-16","article-title":"Hepatic overexpression of CD36 improves glycogen homeostasis and attenuates high-fat diet-induced hepatic steatosis and insulin resistance","volume":"36","author":"Garbacz","year":"2016","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2020071621531374000_B29","doi-asserted-by":"crossref","first-page":"e0145626","DOI":"10.1371\/journal.pone.0145626","article-title":"Deregulated lipid sensing by intestinal CD36 in diet-induced hyperinsulinemic obese mouse model","volume":"11","author":"Buttet","year":"2016","journal-title":"PLoS One"},{"issue":"24","key":"2020071621531374000_B30","doi-asserted-by":"crossref","first-page":"17665","DOI":"10.1016\/S0021-9258(17)46753-6","article-title":"Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36","volume":"268","author":"Abumrad","year":"1993","journal-title":"J Biol Chem"},{"issue":"6","key":"2020071621531374000_B31","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1016\/j.orcp.2014.09.001","article-title":"The associations between polymorphisms in the CD36 gene, fat oxidation and cardiovascular disease risk factors in a young adult Australian population: a pilot study","volume":"8","author":"Jayewardene","year":"2014","journal-title":"Obes Res Clin Pract"},{"issue":"14","key":"2020071621531374000_B32","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1074\/jbc.M800055200","article-title":"Transcriptional regulation of fatty acid translocase\/CD36 expression by CCAAT\/enhancer-binding protein \u03b1","volume":"283","author":"Qiao","year":"2008","journal-title":"J Biol Chem"},{"issue":"6","key":"2020071621531374000_B33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2004.03.012","article-title":"Peroxisome proliferator-activated receptor gamma in diabetes and metabolism","volume":"25","author":"Rangwala","year":"2004","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"2020071621531374000_B34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"1812","author":"Varga","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"13","key":"2020071621531374000_B35","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1096\/fj.04-3253fje","article-title":"EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions","volume":"19","author":"Marleau","year":"2005","journal-title":"FASEB J"},{"issue":"15","key":"2020071621531374000_B36","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.908001","article-title":"Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes","volume":"15","author":"Fern\u00e1ndez","year":"2001","journal-title":"Genes Dev"},{"issue":"10","key":"2020071621531374000_B37","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1007\/s00125-010-1827-4","article-title":"MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity","volume":"53","author":"Vaitheesvaran","year":"2010","journal-title":"Diabetologia"},{"key":"2020071621531374000_B38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12986-015-0003-8","article-title":"The \u03b2-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice","volume":"12","author":"Kumar","year":"2015","journal-title":"Nutr Metab (Lond)"},{"issue":"7","key":"2020071621531374000_B39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/BF03345618","article-title":"Feeding behavior during long-term hexarelin administration in young and old rats","volume":"31","author":"Bresciani","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2020071621531374000_B40","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/en.2013-1291","article-title":"Hexarelin treatment in male ghrelin knockout mice after myocardial infarction","volume":"154","author":"Mao","year":"2013","journal-title":"Endocrinology"},{"issue":"8","key":"2020071621531374000_B41","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1021\/jm070024h","article-title":"Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1","volume":"50","author":"Demange","year":"2007","journal-title":"J Med Chem"},{"issue":"8","key":"2020071621531374000_B42","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/en.2011-0253","article-title":"Development of a method for the determination of pulsatile growth hormone secretion in mice","volume":"152","author":"Steyn","year":"2011","journal-title":"Endocrinology"},{"issue":"4","key":"2020071621531374000_B43","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1172\/JCI17305","article-title":"Muscle-specific PPAR\u03b3-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones","volume":"112","author":"Norris","year":"2003","journal-title":"J Clin Invest"},{"issue":"1","key":"2020071621531374000_B44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ymeth.2007.09.006","article-title":"Real-time PCR quantification of precursor and mature microRNA","volume":"44","author":"Schmittgen","year":"2008","journal-title":"Methods"},{"key":"2020071621531374000_B45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-411619-1.00004-5","article-title":"Imaging of adipose tissue","volume":"537","author":"Berry","year":"2014","journal-title":"Methods Enzymol"},{"issue":"11","key":"2020071621531374000_B46","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2337\/diabetes.53.11.2901","article-title":"Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes","volume":"53","author":"Zhao","year":"2004","journal-title":"Diabetes"},{"issue":"4","key":"2020071621531374000_B47","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.peptides.2009.11.007","article-title":"Hexarelin suppresses high lipid diet and vitamin D3-induced atherosclerosis in the rat","volume":"31","author":"Pang","year":"2010","journal-title":"Peptides"},{"issue":"12","key":"2020071621531374000_B48","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1194\/jlr.M300143-JLR200","article-title":"CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice","volume":"44","author":"Goudriaan","year":"2003","journal-title":"J Lipid Res"},{"issue":"9","key":"2020071621531374000_B49","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2337\/db07-1828","article-title":"Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content","volume":"57","author":"Ravikumar","year":"2008","journal-title":"Diabetes"},{"key":"2020071621531374000_B50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fphys.2011.00112","article-title":"The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise","volume":"2","author":"Jensen","year":"2011","journal-title":"Front Physiol"},{"issue":"3","key":"2020071621531374000_B51","first-page":"693","article-title":"Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man","volume":"78","author":"Ghigo","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071621531374000_B52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1530\/eje.0.1410313","article-title":"Six-week treatment with hexarelin in young dogs: evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and of the orexigenic effect of hexarelin","volume":"141","author":"Rigamonti","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2020071621531374000_B53","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1210\/endo.135.3.7915227","article-title":"Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep","volume":"135","author":"Guillaume","year":"1994","journal-title":"Endocrinology"},{"issue":"10","key":"2020071621531374000_B54","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1210\/en.2013-1209","article-title":"Deletion of growth hormone receptors in postnatal skeletal muscle of male mice does not alter muscle mass and response to pathological injury","volume":"154","author":"Vijayakumar","year":"2013","journal-title":"Endocrinology"},{"issue":"4","key":"2020071621531374000_B55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1310\/hct0904-254","article-title":"Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone","volume":"9","author":"Macallan","year":"2008","journal-title":"HIV Clin Trials"},{"key":"2020071621531374000_B56","first-page":"69","article-title":"Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy","volume":"3","author":"Bedimo","year":"2011","journal-title":"HIV AIDS (Auckl)"},{"issue":"Pt 2","key":"2020071621531374000_B57","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/BJ20040036","article-title":"Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study","volume":"382","author":"Demers","year":"2004","journal-title":"Biochem J"},{"issue":"10","key":"2020071621531374000_B58","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1210\/en.2003-1543","article-title":"Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice","volume":"145","author":"H\u00e9ron-Milhavet","year":"2004","journal-title":"Endocrinology"},{"key":"2020071621531374000_B59","doi-asserted-by":"crossref","unstructured":"Bargut TC , Souza-MelloV, AguilaMB, Mandarim-de-LacerdaCA. Browning of white adipose tissue: lessons from experimental models [published online ahead of print 18 January 2017]. Horm Mol Biol Clin Investig. doi: 10.1515\/hmbci-2016-0051.","DOI":"10.1515\/hmbci-2016-0051"},{"issue":"8","key":"2020071621531374000_B60","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s001250100596","article-title":"Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type II diabetes","volume":"44","author":"Dalgaard","year":"2001","journal-title":"Diabetologia"},{"issue":"35","key":"2020071621531374000_B61","doi-asserted-by":"crossref","first-page":"33370","DOI":"10.1074\/jbc.M305235200","article-title":"Acquirement of brown fat cell features by human white adipocytes","volume":"278","author":"Tiraby","year":"2003","journal-title":"J Biol Chem"},{"issue":"364784","key":"2020071621531374000_B62","article-title":"Hexarelin signaling to PPAR\u03b3 in metabolic diseases","volume":"2008","author":"Demers","year":"2008","journal-title":"PPAR Res"},{"issue":"3","key":"2020071621531374000_B63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"issue":"4","key":"2020071621531374000_B64","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000229506","article-title":"Differences in adipocytokines and fatty acid composition between two adipocyte fractions of small and large cells in high-fat diet-induced obese mice","volume":"54","author":"Matsubara","year":"2009","journal-title":"Ann Nutr Metab"},{"issue":"4","key":"2020071621531374000_B65","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2020071621531374000_B66","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2337\/diabetes.51.4.1042","article-title":"Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation","volume":"51","author":"Albrektsen","year":"2002","journal-title":"Diabetes"},{"issue":"3","key":"2020071621531374000_B67","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1677\/joe.0.1660529","article-title":"Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats","volume":"166","author":"De Gennaro-Colonna","year":"2000","journal-title":"J Endocrinol"},{"issue":"10","key":"2020071621531374000_B68","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1210\/jcem.86.10.8098","article-title":"Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans","volume":"86","author":"Broglio","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2020071621531374000_B69","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00125-004-1581-6","article-title":"Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes","volume":"47","author":"Kim","year":"2004","journal-title":"Diabetologia"},{"issue":"5709","key":"2020071621531374000_B70","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1126\/science.1106561","article-title":"Interindividual variation in posture allocation: possible role in human obesity","volume":"307","author":"Levine","year":"2005","journal-title":"Science"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/158\/10\/3174\/20424678\/en.2017-00168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/158\/10\/3174\/20424678\/en.2017-00168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:33:50Z","timestamp":1659227630000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/158\/10\/3174\/3964576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2017-00168","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10,1]]},"published":{"date-parts":[[2017,7,14]]}}}